Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Final Results of a Prospective Randomized Multicenter Phase III Trial Comparing Treosulfan/Fludarabine to Reduced Intensity Conditioning with Busulfan/Fludarabine Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Elderly or Comorbid Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Dietrich W Beelen, MD PhD, Rudolf Trenschel, MD, Matthias Stelljes, MD, Tamás Masszi, MD Prof., Péter Reményi, Eva-Maria Maria Wagner-Drouet, MD, Peter Dreger, MD Prof., Wolfgang Bethge, MD Prof., Fabio Ciceri, MD, Friedrich Stoelzel, MD, Christian Junghanss, MD, Mauricette Michallet, MD Prof., Miroslaw Markiewicz, MD Prof.

Blood (2017) 130 (Supplement 1): 521.

https://doi.org/10.1182/blood.V130.Suppl_1.521.521

Published: 2017

Journal Articles

Allo-HCT from MUD/MRD for Paroxysmal Nocturnal Hemoglobinuria - 12 Years of Experience

Miroslaw Markiewicz, MD, PhD, Prof., Malwina Rybicka-Ramos, MD, Ph. D., Monika Dzierzak-Mietla, MD, PhD, Anna Koclega, MD, PhD, Krzysztof Bialas, MD, Ewa Mendek-Czajkowska, MD, PhD, Slawomira Kyrcz-Krzemien, Prof

Blood (2016) 128 (22): 5886.

https://doi.org/10.1182/blood.V128.22.5886.5886

Published: 2016

Journal Articles

No Influence of Post-Transplant Anti-HLA Antibodies on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Mismatched Unrelated Donors

Anna Koclega, MD, PhD, Miroslaw Markiewicz, MD, PhD, Prof., Sylwia Mizia, MSci, Urszula Siekiera, BSci, Alicja Dobrowolska, Monika Dzierzak-Mietla, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2015) 126 (23): 5538.

https://doi.org/10.1182/blood.V126.23.5538.5538

Published: 2015

Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 2564.

https://doi.org/10.1182/blood.V124.21.2564.2564

Published: 2014

Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 5934.

https://doi.org/10.1182/blood.V124.21.5934.5934

Published: 2014

Journal Articles

Allo-HSCT from MUD/MRD As a Curative Treatment in Paroxysmal Nocturnal Hemoglobinuria

Miroslaw Markiewicz, MD PhD, Anna Koclega, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Ewa Mendek-Czajkowska, MD PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 1251.

https://doi.org/10.1182/blood.V124.21.1251.1251

Published: 2014

Journal Articles

Acceptable Results Of Allo-HSCT From Unrelated Donors In AML Patients Who Failed To Achieve The Complete Remission

Miroslaw Markiewicz, MD, PhD, Monika Dzierzak-Mietla, MD, PhD, Malwina Rybicka, MD, Magdalena Gaj, MD, Anna Koclega, MD, PhD, Patrycja Zielinska, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD

Blood (2013) 122 (21): 5520.

https://doi.org/10.1182/blood.V122.21.5520.5520

Published: 2013

Journal Articles

The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Miroslaw Markiewicz, MD, PhD, Anna Koclega, MD, PhD, Sylwia Mizia, MSci, Urszula Siekiera, PhD, Alicja Dobrowolska, Monika Dzierzak-Mietla, MD, PhD, Patrycja Zielinska, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD

Blood (2013) 122 (21): 4542.

https://doi.org/10.1182/blood.V122.21.4542.4542

Published: 2013

Journal Articles

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Malgorzata Sobczyk-Kruszelnicka, Miroslaw Markiewicz, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Agnieszka Wieclawek, Anna Soja, Monika Dzierzak-Mietla, MD, Anna Koclega, Krzysztof Bialas, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2012) 120 (21): 4494.

https://doi.org/10.1182/blood.V120.21.4494.4494

Published: 2012

Journal Articles

Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Anna Koclega, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Alicja Dobrowolska, Sylwia Mizia, MSci, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4475.

https://doi.org/10.1182/blood.V120.21.4475.4475

Published: 2012

Journal Articles

Influence of Minor Histocompatibility Antigens' Disparities On Graft Versus Host Disease and Overall Survival After Allogeneic Hematopoietic Cell Transplantation From Siblings

Monika Dzierzak-Mietla, MD, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Sylwia Mizia, MSci, Agnieszka Karolczyk, Anna Koclega, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4172.

https://doi.org/10.1182/blood.V120.21.4172.4172

Published: 2012

Journal Articles

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Irena Frydecka, MD, PhD, Lidia Karabon, PhD, Edyta Pawlak-Adamska, PhD, Anna Tomkiewicz, MSc, Tomasz Wrobel, prof., Miroslaw Markiewicz, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2011) 118 (21): 2010.

https://doi.org/10.1182/blood.V118.21.2010.2010

Published: 2011

Journal Articles

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

Miroslaw Markiewicz, MD, PhD, Monika Dzierzak-Mietla, MD, Katarzyna Wisniewska-Piaty, MD, Andrzej Frankiewicz, MD, Anna Koclega, MD, Patrycja Zielinska, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Malgorzata Sobczyk-Kruszelnicka, MD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien

Blood (2011) 118 (21): 4145.

https://doi.org/10.1182/blood.V118.21.4145.4145

Published: 2011

Journal Articles

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

Miroslaw Markiewicz, MD, PhD, Dzierzak Mietla Monika, MD, Patrycja Zielinska, Tomasz Kruzel, MD, Tomasz Czerw, MD, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 3498.

https://doi.org/10.1182/blood.V116.21.3498.3498

Published: 2010

Journal Articles

DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Tomasz Kruzel, MD, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD, Slawomira Kyrcz-Krzemien, Prof, MD, PhD

Blood (2010) 116 (21): 4575.

https://doi.org/10.1182/blood.V116.21.4575.4575

Published: 2010

Journal Articles

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

Miroslaw Markiewicz, MD, Urszula Siekiera, Jerzy Wojnar, MD,PhD, Iwona Wylezol, MD, Sebastian Giebel, MD, Monika Dzierzak, MD, Agnieszka Karolczyk, Jerzy Holowiecki, MD,PhD

Blood (2007) 110 (11): 3070.

https://doi.org/10.1182/blood.V110.11.3070.3070

Published: 2007

Journal Articles

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Aleksandra Holowiecka-Goral, MD, Sebastian Giebel, MD, Izabela Nowak, PhD, Tomasz Czerw, MD, Jerzy Wojnar, MD, Malgorzata Krawczyk-Kulis, MD, Elzbieta Pietruszka, PhD, Miroslaw Markiewicz, MD, Piotr Kusnierczyk, MD, Iwona Wylezol, MD, Jerzy Holowiecki Prof

Blood (2007) 110 (11): 2968.

https://doi.org/10.1182/blood.V110.11.2968.2968

Published: 2007

Journal Articles

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Jerzy Wojnar, MD, Sebastian Giebel, MD, Miroslaw Markiewicz, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Beata Stella-Holowiecka, MD, Tomasz Kruzel, MD, Jerzy Holowiecki

Blood (2006) 108 (11): 5245.

https://doi.org/10.1182/blood.V108.11.5245.5245

Published: 2006

Journal Articles

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, Dr of Biol Sci, Jerzy Wojnar, MD, Assoc., Agata Wieczorkiewicz, MD, Iwona Wylezol, MD, PhD, Sebastian Giebel, MD, PhD, Agnieszka Karolczyk, Biol., Jerzy Holowiecki, MD

Blood (2006) 108 (11): 3156.

https://doi.org/10.1182/blood.V108.11.3156.3156

Published: 2006

Journal Articles

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Sebastian Giebel, MD, Tomasz Czerw, MD, Izabela Nowak, PhD, Jerzy Wojnar, MD, Tomasz Kruzel, MD, Joanna Dziaczkowska, PhD, Miroslaw Markiewicz, MD, Aleksandra Holowiecka-Goral, MD, Agnieszka Karolczyk, PhD, Iwona Wylezol, MD, Piotr Kusnierczyk, PhD, Jerzy Holowiecki

Blood (2006) 108 (11): 3113.

https://doi.org/10.1182/blood.V108.11.3113.3113

Published: 2006

NARROW

Allo-HCT from MUD/MRD for Paroxysmal Nocturnal Hemoglobinuria - 12 Years of Experience

No Influence of Post-Transplant Anti-HLA Antibodies on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Mismatched Unrelated Donors

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Allo-HSCT from MUD/MRD As a Curative Treatment in Paroxysmal Nocturnal Hemoglobinuria

Acceptable Results Of Allo-HSCT From Unrelated Donors In AML Patients Who Failed To Achieve The Complete Remission

The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Influence of Minor Histocompatibility Antigens' Disparities On Graft Versus Host Disease and Overall Survival After Allogeneic Hematopoietic Cell Transplantation From Siblings

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

Caphosol Mouth Rinse Diminishes Oral Mucositis In Allo-HSCT Recipients.

DynaChip Anti-HLA Antibody Analysis In Sera of Patients Following Allo-HSCT From HLA-Mismatched Unrelated Donors.

Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.

The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Beyond HLA: Impact of Immunoreactive Mismatches of Minor Histocompatibility Antigens on Probability of Relapse and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation from HLA-Matched Unrelated Donors.

Impaired Survival after Unrelated Hematopoietic Stem Cell Transplantation from KIR2DS1 and KIR2DS2 Positive Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only